None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ? moderate or severe hot flashes symptoms according to the definition of the Food and Drug Administration ? an average of 3 or more hot flashes per week during the 1-week period before study entry ? voluntary participation ? follow-up for the duration of the study ? cessation of HRT or other pharmacologic or alternative treatments for hot flashes at least 4 weeks before the trial, if such treatments were used
Exclusion criteria
Exclusion criteria: ? pharmacologic or other alternative treatment for hot flashes during the trial ? serious medical or psychiatric conditions making participation in the trial unsuitable ? hot flashes caused by menopause without antiestrogen therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| severity of hot flashes ? visual analogue scale (VAS) ? total hot flash score | — |
Secondary
| Measure | Time frame |
|---|---|
| QoL of the participants: the EORTC QLQ-C30 version 3.0 questionnaire and the EORTC QLQ-BR23 | — |
Countries
Korea, Republic of
Contacts
Daegu Catholic University Medical Center